UIQK:F:F-UBS (Irl) Fund Solutions plc - CMCI Composite SF UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 97.57

Change

-3.83 (-3.78)%

Market Cap

USD 0.99B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SXR8:F iShares Core S&P 500 UCITS ETF..

+2.54 (+0.51%)

USD 108.00B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.71 (+1.59%)

USD 105.67B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.78 (+1.59%)

USD 104.83B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.21 (+1.59%)

USD 62.86B
VUSA:F Vanguard Funds Public Limited ..

+1.12 (+1.27%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.85 (+1.40%)

USD 49.04B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 41.48B
0ZC:F Zscaler Inc

-6.90 (-3.80%)

USD 37.92B
BSND:F Danone SA

+0.20 (+1.45%)

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+5.70 (+5.23%)

USD 24.77B

ETFs Containing UIQK:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.36% 47% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.36% 47% F 56% F
Trailing 12 Months  
Capital Gain -0.59% 32% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.59% 30% F 45% F
Trailing 5 Years  
Capital Gain 120.20% 90% A- 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 120.20% 90% A- 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 20.35% 94% A 81% B-
Dividend Return 20.35% 92% A 73% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 23.08% 17% F 61% D-
Risk Adjusted Return 88.15% 84% B 88% B+
Market Capitalization 0.99B 73% C 56% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.